https://m2.mtmt.hu/ eng 2026-05-30 13:49 JournalArticle 32127951 VALIDATED true Export Date: 30 April 2026; Cited By: 728; Correspondence Address: B. Győrffy; Department of Bioinformatics, Semmelweis University, Budapest, Tüzoltó u. 7-9, 1094, Hungary; email: gyorffy.balazs@med.semmelweis-univ.hu; 0 false 2026-05-27T13:51:17.849+0000 2026-04-30T12:02:02.717+0000 2021-08-10T06:55:51.896+0000 true 10023751 Haltrich Irén /api/author/10023751 Author Irén Haltrich (Biológia, genetika) true 10023751 2026-04-30T12:02:02.524+0000 2024-12-06T17:59:01.948+0000 true 10039043 Milánkovics Róbert /api/admin/10039043 Admin Róbert Milánkovics (PTE ÁOK admin 4) true 10039043 true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Győrffy, Balázs true true /api/journal/10046092 REVIEWED COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 2001-0370 2001-0370 true false 10046092 false 10046092 true 2001-0370 2001-0370 Journal FOREIGN 19 4101 4109 4101 9 2021 Funding 2010900 /api/funding/2010900 Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Funder: Ministry for Innovation and Technology false true Funding 2010901 /api/funding/2010901 Magyar-koreai kutatás-fejlesztési együttműködési pályázat(2018-2.1.17-TÉT-KR-00001) Funder: NKFIH false true Funding 2010902 /api/funding/2010902 (FIEK_16-1-2016-0005) false true Funding 2010903 /api/funding/2010903 (2018-1.3.1-VKE-2018-00032) false true Funding 2010904 /api/funding/2010904 (ELIXIR Hungary) false true Funding 2010905 /api/funding/2010905 (the Bionic thematic programme of the Semmelweis University) false true true 2021 true true true false true false NONE 2026-05-27 false 763 0 763 746 22 761 754 738 640 760 760 743 743 746 17 0 763 746 763 746 0 10 10 Folyóiratcikk Journal Article 24 751 Könyvrészlet Chapter in Book 25 9 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 3 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2021 0 32 32 32 32 2022 0 175 172 175 172 2023 0 140 137 140 137 2024 0 189 186 189 186 2025 0 171 166 171 166 2026 0 56 53 56 53 D1 false 10000109 false false false 2021-08-15T08:14:43.897+0000 Bioinformatika Tanszék (SE / AOK / I); II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI) 1 26 3 1 0 true Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 97002234 /api/authorship/97002234 Győrffy, Balázs ✉ [Győrffy, Balázs (Onkológia), author] II. Department of Pediatrics (SU / FM / C); Enzim_417 (IMLS); Bioinformatika Tanszék (SU / FM / I) 1 1.0 true false true Author 10000109 /api/author/10000109 Balázs Győrffy (Onkológia) Győrffy Balázs true 10000109 true Győrffy Balázs true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 19079501 /api/publicationidentifier/19079501 DOI: 10.1016/j.csbj.2021.07.014 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.csbj.2021.07.014 https://doi.org/10.1016/j.csbj.2021.07.014 false true PublicationIdentifier 19188944 /api/publicationidentifier/19188944 WoS: 000684852400013 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000684852400013 https://www.webofscience.com/wos/woscc/full-record/000684852400013 false true PublicationIdentifier 19079503 /api/publicationidentifier/19079503 Scopus: 85111315910 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85111315910 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85111315910 false true PublicationIdentifier 20639300 /api/publicationidentifier/20639300 PubMed: 34527184 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34527184 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34527184&dopt=Abstract false true PublicationIdentifier 31935133 /api/publicationidentifier/31935133 Other URL: https://www.scopus.com/pages/publications/85111315910?origin=resultslist PlainSource 40 /api/publicationsource/40 Other URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true NONE IDENTICAL https://www.scopus.com/pages/publications/85111315910?origin=resultslist https://www.scopus.com/pages/publications/85111315910?origin=resultslist false true SjrRating 11196560 /api/sjrrating/11196560 sjr:D1 (2021) Scopus - Biophysics COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 2001-0370 8 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1304 /api/classificationexternal/1304 Scopus - Biophysics true 1304 true D1 DIRECT true true Reference 22102458 /api/reference/22102458 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7–30. https://doi.org/10.3322/caac.21590., DOI: 10.3322/caac.21590 1 10.3322/caac.21590 false true Reference 22102459 /api/reference/22102459 2. Lester 2016: Diagnostic pathology: breast 2 false true Reference 22102460 /api/reference/22102460 3. Waks 2019: Breast cancer treatment: A review., JAMA, 321, p. 288, DOI: 10.1001/jama.2018.19323 3 10.1001/jama.2018.19323 false true Reference 22102461 /api/reference/22102461 4. Piccart-Gebhart 2005: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer., N Engl J Med, 353, p. 1659, DOI: 10.1056/NEJMoa052306 4 10.1056/NEJMoa052306 false true Reference 22102462 /api/reference/22102462 5. Foulkes 2010: Triple-negative breast cancer., N Engl J Med, 363, p. 1938, DOI: 10.1056/NEJMra1001389 5 10.1056/NEJMra1001389 false true Reference 22102463 /api/reference/22102463 6. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. JNCI: J Natl Cancer Inst 2014;106. https://doi.org/10.1093/jnci/dju055., DOI: 10.1093/jnci/dju055 6 10.1093/jnci/dju055 false true Reference 22102464 /api/reference/22102464 7. Pernas S, Tolaney SM, Winer EP, Goel S. CDK4/6 inhibition in breast cancer: current practice and future directions. Ther Adv Med Oncol 2018;10:175883591878645. https://doi.org/10.1177/1758835918786451., DOI: 10.1177/1758835918786451 7 10.1177/1758835918786451 false true Reference 22102465 /api/reference/22102465 8. Robson 2017: Olaparib for metastatic breast cancer in patients with a germline BRCA mutation., N Engl J Med, 377, p. 523, DOI: 10.1056/NEJMoa1706450 8 10.1056/NEJMoa1706450 false true Reference 22102466 /api/reference/22102466 9. Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther 2017;4. https://doi.org/10.15761/ICST.1000228., DOI: 10.15761/ICST.1000228 9 10.15761/ICST.1000228 false true Reference 22102467 /api/reference/22102467 10. Győrffy 2015: Multigene prognostic tests in breast cancer: past, present, future., Breast Cancer Res, 17, p. 11, DOI: 10.1186/s13058-015-0514-2 10 10.1186/s13058-015-0514-2 false true Reference 22102468 /api/reference/22102468 11. Samaan 1981: Estrogen receptor: a prognostic factor in breast cancer., Cancer, 47, p. 554, DOI: 10.1002/1097-0142(19810201)47:3&lt;554::AID-CNCR2820470322&gt;3.0.CO;2-W 11 10.1002/1097-0142(19810201)47:3&lt;554::AID-CNCR2820470322&gt;3.0.CO;2-W false true Reference 22102469 /api/reference/22102469 12. Slamon 1987: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene., Science, 235, p. 177, DOI: 10.1126/science.3798106 12 10.1126/science.3798106 false true Reference 22102470 /api/reference/22102470 13. Gyorffy 2009: Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples., PLoS ONE, 4, p. e5645, DOI: 10.1371/journal.pone.0005645 13 10.1371/journal.pone.0005645 false true Reference 22102471 /api/reference/22102471 14. Fekete 2012: Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples., Int J Cancer, 131, p. 95, DOI: 10.1002/ijc.26364 14 10.1002/ijc.26364 false true Reference 22102472 /api/reference/22102472 15. Goldhirsch 2013: Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013., Ann Oncol, 24, p. 2206, DOI: 10.1093/annonc/mdt303 15 10.1093/annonc/mdt303 false true Reference 22102473 /api/reference/22102473 16. Mihály 2013: Improving pathological assessment of breast cancer by employing array-based transcriptome analysis., Microarrays (Basel), 2, p. 228, DOI: 10.3390/microarrays2030228 16 10.3390/microarrays2030228 false true Reference 22102474 /api/reference/22102474 17. Huang 2009: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources., Nat Protoc, 4, p. 44, DOI: 10.1038/nprot.2008.211 17 10.1038/nprot.2008.211 false true Reference 22102475 /api/reference/22102475 18. Györffy 2010: An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients., Breast Cancer Res Treat, 123, p. 725, DOI: 10.1007/s10549-009-0674-9 18 10.1007/s10549-009-0674-9 false true Reference 22102476 /api/reference/22102476 19. Li 2011: Jetset: selecting the optimal microarray probe set to represent a gene., BMC Bioinf, 12, p. 474, DOI: 10.1186/1471-2105-12-474 19 10.1186/1471-2105-12-474 false true Reference 22102477 /api/reference/22102477 20. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012;379:432–44. https://doi.org/10.1016/S0140-6736(11)61625-5., DOI: 10.1016/S0140-6736(11)61625-5 20 10.1016/S0140-6736(11)61625-5 false true Reference 22102478 /api/reference/22102478 21. Dickens 2018: Principles of cancer treatment by chemotherapy., Surgery (Oxford), 36, p. 134, DOI: 10.1016/j.mpsur.2017.12.002 21 10.1016/j.mpsur.2017.12.002 false true Reference 22102479 /api/reference/22102479 22. Wagner 2020: Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx., J Clin Oncol, 38, p. 1875, DOI: 10.1200/JCO.19.01866 22 10.1200/JCO.19.01866 false true Reference 22102480 /api/reference/22102480 23. Mihály 2013: A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer., Breast Cancer Res Treat, 140, p. 219, DOI: 10.1007/s10549-013-2622-y 23 10.1007/s10549-013-2622-y false true Reference 22102481 /api/reference/22102481 24. Sparano 2019: Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer., N Engl J Med, 380, p. 2395, DOI: 10.1056/NEJMoa1904819 24 10.1056/NEJMoa1904819 false true Reference 22102482 /api/reference/22102482 25. Sparano 2018: Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer., N Engl J Med, 379, p. 111, DOI: 10.1056/NEJMoa1804710 25 10.1056/NEJMoa1804710 false true Reference 22102483 /api/reference/22102483 26. Almstedt 2020: EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer., Breast Cancer Res Treat, 182, p. 137, DOI: 10.1007/s10549-020-05688-1 26 10.1007/s10549-020-05688-1 false true Reference 22102484 /api/reference/22102484 27. Mitchison 2012: The proliferation rate paradox in antimitotic chemotherapy., Mol Biol Cell, 23, p. 1, DOI: 10.1091/mbc.e10-04-0335 27 10.1091/mbc.e10-04-0335 false true Reference 22102485 /api/reference/22102485 28. Bertucci 2012: Basal breast cancer: a complex and deadly molecular subtype., Curr Mol Med, 12, p. 96, DOI: 10.2174/156652412798376134 28 10.2174/156652412798376134 false true Reference 22102486 /api/reference/22102486 29. Bianchini 2010: Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers., J Clin Oncol, 28, p. 4316, DOI: 10.1200/JCO.2009.27.2419 29 10.1200/JCO.2009.27.2419 false true Reference 22102487 /api/reference/22102487 30. Lehmann 2016: Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection., PLoS ONE, 11, p. e0157368, DOI: 10.1371/journal.pone.0157368 30 10.1371/journal.pone.0157368 false true Reference 22102488 /api/reference/22102488 31. Pusztai 2016: New strategies in breast cancer: immunotherapy., Clin Cancer Res, 22, p. 2105, DOI: 10.1158/1078-0432.CCR-15-1315 31 10.1158/1078-0432.CCR-15-1315 false true Reference 22102489 /api/reference/22102489 32. Tegze 2012: Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance., PLoS ONE, 7, p. e30804, DOI: 10.1371/journal.pone.0030804 32 10.1371/journal.pone.0030804 false true Reference 22102490 /api/reference/22102490 33. Coates 2015: Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015., Ann Oncol, 26, p. 1533, DOI: 10.1093/annonc/mdv221 33 10.1093/annonc/mdv221 false true Reference 22102491 /api/reference/22102491 34. Fletcher 2010: ABC transporters in cancer: more than just drug efflux pumps., Nat Rev Cancer, 10, p. 147, DOI: 10.1038/nrc2789 34 10.1038/nrc2789 false true Reference 22102492 /api/reference/22102492 35. Fujiki 2018: APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer., Oncotarget, 9, p. 30513, DOI: 10.18632/oncotarget.25495 35 10.18632/oncotarget.25495 false true Reference 22102493 /api/reference/22102493 36. Nguyen 2020: Association of independent prognostic factors and treatment modality with survival and recurrence outcomes in breast cancer., JAMA Netw Open, 3, p. e207213, DOI: 10.1001/jamanetworkopen.2020.7213 36 10.1001/jamanetworkopen.2020.7213 false true Reference 22102494 /api/reference/22102494 37. Munkácsy 2010: PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer., Br J Cancer, 102, p. 361, DOI: 10.1038/sj.bjc.6605478 37 10.1038/sj.bjc.6605478 false true Reference 22102495 /api/reference/22102495 38. Pénzváltó 2014: MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer., BMC Cancer, 14, p. 837, DOI: 10.1186/1471-2407-14-837 38 10.1186/1471-2407-14-837 false true /api/publication/32127951 Győrffy Balázs. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. (2021) COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 2001-0370 2001-0370 19 4101-4109<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10000109"><a href="/gui2/?type=authors&mode=browse&sel=10000109" target="_blank">Győrffy Balázs ✉ (<span class="authorship-author-name">Győrffy Balázs</span> <span class="authorAux-mtmt"> Onkológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/II. Department of Pediatrics; <span title="Research Centre for Natural Sciences">RCNS</span>/<span title="Institute of Enzymology">EI</span>/Enzim_417; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Bioinformatika Tanszék</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32127951" target="_blank">Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer</a></div> <div> <span class="journal-title">COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2001-0370">2001-0370</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2001-0370">2001-0370</a>)</span>: <span class="journal-volume">19</span> <span class="page"> pp 4101-4109 </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.csbj.2021.07.014" target="_blank" href="https://doi.org/10.1016/j.csbj.2021.07.014"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000684852400013" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000684852400013"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85111315910" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85111315910"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34527184" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34527184&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_NONE" title=" None "> <a style="color:blue" title="https://www.scopus.com/pages/publications/85111315910?origin=resultslist" target="_blank" href="https://www.scopus.com/pages/publications/85111315910?origin=resultslist"> Other URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Biophysics&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Biochemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Biotechnology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Computer Science Applications&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Genetics&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Structural Biology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 763</span> | Independent citation: 746 | Self citation: 17 | Unknown citation: 0 | Number of citations in WoS: 738 | Number of citations in Scopus:&nbsp;640 | WoS/Scopus assigned:&nbsp;760 | Number of citations with DOI:&nbsp;754 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32127951&sort=publishedYear,desc&sort=title"> Number of cited publications: 10 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 32127951</span> | <span class="status-data status-VALIDATED"> Validated </span> Core Citing | <span class="type-subtype">Journal Article ( Article ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Funder: Ministry for Innovation and Technology, Magyar-koreai kutatás-fejlesztési együttműködési pályázat(2018-2.1.17-TÉT-KR-00001) Funder: NKFIH, (FIEK_16-1-2016-0005), (2018-1.3.1-VKE-2018-00032), (ELIXIR Hungary), (the Bionic thematic programme of the Semmelweis University) </div> <div class="lastModified">Last Modified: 2026.04.30. 14:02 Zóra Kondor (SE_KK_Admin5_KZ, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Export Date: 30 April 2026; Cited By: 728; Correspondence Address: B. Győrffy; Department of Bioinformatics, Semmelweis University, Budapest, Tüzoltó u. 7-9, 1094, Hungary; email: gyorffy.balazs@med.semmelweis-univ.hu;</pre> </div></div>